PharmaResources (Shanghai) Co., Ltd. Share Price

Equities

301230

CNE1000065Q9

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. 03:30:00 14/05/2024 am IST 5-day change 1st Jan Change
41.64 CNY +20.00% Intraday chart for PharmaResources (Shanghai) Co., Ltd. +15.54% +16.31%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 852M 118M 9.84B Sales 2025 * 1.12B 155M 12.93B Capitalization 3.9B 540M 45.05B
Net income 2024 * 146M 20.21M 1.69B Net income 2025 * 195M 27M 2.25B EV / Sales 2024 * 4.58 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 3.48 x
P/E ratio 2024 *
30.8 x
P/E ratio 2025 *
23 x
Employees 1,047
Yield 2024 *
-
Yield 2025 *
-
Free-Float 31.83%
More Fundamentals * Assessed data
Dynamic Chart
1 day+20.00%
1 week+15.54%
Current month+19.24%
1 month+19.41%
3 months+65.90%
6 months+4.49%
Current year+16.31%
More quotes
1 week
34.59
Extreme 34.59
42.00
1 month
29.10
Extreme 29.1
42.00
Current year
21.16
Extreme 21.16
54.99
1 year
21.16
Extreme 21.16
57.50
3 years
21.16
Extreme 21.16
57.50
5 years
21.16
Extreme 21.16
57.50
10 years
21.16
Extreme 21.16
57.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 14/07/14
Director of Finance/CFO 47 01/14/01
Director/Board Member 38 01/09/01
Members of the board TitleAgeSince
Director/Board Member 69 01/20/01
Director/Board Member 51 01/13/01
Director/Board Member 60 01/20/01
More insiders
Date Price Change Volume
14/24/14 41.64 +20.00% 18,184,540
13/24/13 34.7 -5.22% 7,276,979
10/24/10 36.61 -3.25% 7,058,820
09/24/09 37.84 -1.07% 9,960,558
08/24/08 38.25 +6.13% 9,957,152

End-of-day quote Shenzhen S.E., May 14, 2024

More quotes
PharmaResources Shanghai Co Ltd is a China-based company mainly engaged in the development and commercial production of new drugs. The Company's main businesses include drug discovery, process research and development and commercial manufacturing business. The drug discovery business includes medicinal chemistry, synthetic chemistry and pharmacokinetics. The process research and development business includes process chemistry and process development as well as bulk drug research. The commercial manufacturing business includes customized manufacturing of new drugs and the research and development, production and sales of proprietary generic drug products. The Company distributes its products to the United States, India and other countries.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
41.64
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 301230 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW